Remove Drug Development Remove Health Analytics Remove Pharmaceuticals
article thumbnail

Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Lloyd Price

Exec Summary: Merative, formerly known as IBM Watson Health, is gearing up to introduce a range of new products in 2025. This comes after Francisco Partners, a private equity firm, acquired the health analytics assets of IBM Watson Health in 2022 and rebranded the division as Merative.

article thumbnail

HealthTech M&A 2025 Predictions: Europe and USA

Lloyd Price

Several key trends and predictions are emerging: Increased focus on digital health and AI: AI-powered diagnostics and drug discovery: Companies specialising in AI-driven medical imaging, genomics analysis, and drug development are likely to attract significant interest from larger pharmaceutical and technology firms.